Handelsbanken Fonder’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
59,922
+8,354
| +16% | +$1.83M | 0.05% | 316 |
|
|
2025
Q1 | $11.5M | Sell |
51,568
-4,111
| -7% | -$920K | 0.05% | 316 |
|
|
2024
Q4 | $18.2M | Buy |
55,679
+4,940
| +10% | +$1.62M | 0.07% | 262 |
|
|
2024
Q3 | $15.2M | Sell |
50,739
-31
| -0.1% | -$9.31K | 0.06% | 280 |
|
|
2024
Q2 | $16.7M | Buy |
50,770
+8,662
| +21% | +$2.85M | 0.07% | 239 |
|
|
2024
Q1 | $16.7M | Buy |
42,108
+2,258
| +6% | +$894K | 0.07% | 250 |
|
|
2023
Q4 | $14M | Sell |
39,850
-10,805
| -21% | -$3.8M | 0.07% | 272 |
|
|
2023
Q3 | $19M | Buy |
50,655
+158
| +0.3% | +$59.3K | 0.11% | 198 |
|
|
2023
Q2 | $19.3M | Buy |
50,497
+1,855
| +4% | +$709K | 0.1% | 216 |
|
|
2023
Q1 | $16.9M | Buy |
48,642
+3,314
| +7% | +$1.15M | 0.1% | 236 |
|
|
2022
Q4 | $10.7M | Buy |
45,328
+25,073
| +124% | +$5.9M | 0.07% | 296 |
|
|
2022
Q3 | $4.98M | Buy |
20,255
+600
| +3% | +$148K | 0.03% | 416 |
|
|
2022
Q2 | $5.94M | Buy |
19,655
+1,300
| +7% | +$393K | 0.04% | 397 |
|
|
2022
Q1 | $7.54M | Sell |
18,355
-595
| -3% | -$244K | 0.04% | 385 |
|
|
2021
Q4 | $8.89M | Sell |
18,950
-878
| -4% | -$412K | 0.04% | 369 |
|
|
2021
Q3 | $8.42M | Hold |
19,828
| – | – | 0.04% | 376 |
|
|
2021
Q2 | $7.12M | Buy |
19,828
+2,000
| +11% | +$718K | 0.04% | 417 |
|
|
2021
Q1 | $5.02M | Buy |
17,828
+398
| +2% | +$112K | 0.03% | 433 |
|
|
2020
Q4 | $4.94M | Buy |
17,430
+4,135
| +31% | +$1.17M | 0.03% | 411 |
|
|
2020
Q3 | $3.66M | Hold |
13,295
| – | – | 0.03% | 426 |
|
|
2020
Q2 | $3.02M | Buy |
+13,295
| New | +$3.02M | 0.03% | 437 |
|